Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOZANTINIB S-MALATE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

29.9%
Female
70.1%
Male

Age Information

The average age of patients reporting adverse events with CABOZANTINIB S-MALATE is 65.0 years.

Geographic Distribution

The majority of adverse event reports for CABOZANTINIB S-MALATE originate from US.

Report Summary & Outcomes

39,270
Total Reports
39,270
As Primary/Secondary Suspect
4,203
Deaths Reported
6,193
Hospitalizations
423
Life-Threatening
187
Disabilities

Reporting Timeline

First adverse event report: 2013. Most recent report: 20250911. View full timeline →

More About CABOZANTINIB S-MALATE

CABOZANTINIB S-MALATE Full Profile Reports by Year Drug Interactions